Becton Dickinson and Co (BDX)

Common Stock

Sell: $142.05|Buy: $142.50|Change: 1.12 (-0.78%)

Open

$143.95

Previous close

$143.47

Trade high

$145.58

Volume

3,814,083

Year high

$187.35

Year low

$127.625

Dividend yield

2.91%

Market capitalisation

$39.22 bn

P/E ratio

25.04

ISIN

US0758871091

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPP

Share price

Dividends

	Previous	Latest
Record date	10/03/2026	09/06/2026
Ex-dividend date	10/03/2026	09/06/2026
Payment date	31/03/2026	30/06/2026
Amount	$1.05	$1.05

Performance 18/05/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Becton Dickinson and Co	- 0.78
More...

Company profile

Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Sector

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.